{
  "version": "3.0.0",
  "last_updated": "2025-10-08",
  "description": "Renal dose adjustment rules for antibiotics",

  "crcl_categories": {
    "normal": {
      "crcl_min": 60,
      "crcl_max": 999,
      "description": "Normal renal function"
    },
    "mild_impairment": {
      "crcl_min": 30,
      "crcl_max": 59,
      "description": "Mild renal impairment"
    },
    "moderate_impairment": {
      "crcl_min": 15,
      "crcl_max": 29,
      "description": "Moderate renal impairment"
    },
    "severe_impairment": {
      "crcl_min": 0,
      "crcl_max": 14,
      "description": "Severe renal impairment"
    },
    "dialysis": {
      "description": "Hemodialysis or peritoneal dialysis",
      "keywords": ["hemodialysis", "HD", "dialysis", "ESRD"]
    }
  },

  "drugs_requiring_adjustment": {
    "cefepime": {
      "adjustment_required": true,
      "normal": "2 g IV q8h",
      "crcl_30_60": "2 g IV q12h",
      "crcl_15_29": "1 g IV q12h",
      "crcl_lt_15": "1 g IV q24h",
      "dialysis": "1 g IV after each dialysis session",
      "note": "Dose reduction critical to prevent neurotoxicity"
    },
    "piperacillin_tazobactam": {
      "adjustment_required": true,
      "normal": "3.375-4.5 g IV q6-8h",
      "crcl_20_40": "2.25 g IV q6h",
      "crcl_lt_20": "2.25 g IV q8h",
      "dialysis": "2.25 g IV q8h + 0.75 g after each dialysis",
      "note": "Extended infusion dosing may differ"
    },
    "aztreonam": {
      "adjustment_required": true,
      "normal": "2 g IV q8h",
      "crcl_10_30": "1 g IV q8h (50% reduction)",
      "crcl_lt_10": "500 mg IV q8h (75% reduction)",
      "dialysis": "Give after dialysis",
      "note": "Significant dose reduction needed"
    },
    "vancomycin": {
      "adjustment_required": true,
      "monitoring": "trough levels",
      "normal": "15-20 mg/kg IV q8-12h",
      "crcl_30_60": "15-20 mg/kg IV q12-24h",
      "crcl_10_29": "15-20 mg/kg IV q24-48h",
      "crcl_lt_10": "15-20 mg/kg IV q48-72h OR based on levels",
      "dialysis": "Give after dialysis, dose by levels",
      "note": "MUST monitor trough levels. Nephrotoxic."
    },
    "ceftriaxone": {
      "adjustment_required": false,
      "normal": "1-2 g IV q24h",
      "note": "NO renal adjustment needed. Hepatic clearance."
    },
    "metronidazole": {
      "adjustment_required": false,
      "normal": "500 mg IV q8h",
      "dialysis": "Give after dialysis",
      "note": "NO renal adjustment for impairment. Hepatic metabolism."
    },
    "levofloxacin": {
      "adjustment_required": true,
      "normal": "750 mg IV q24h",
      "crcl_20_49": "750 mg IV x1, then 750 mg IV q48h",
      "crcl_10_19": "750 mg IV x1, then 500 mg IV q48h",
      "dialysis": "750 mg IV x1, then 500 mg q48h",
      "note": "Complex dosing schedule for renal impairment"
    },
    "azithromycin": {
      "adjustment_required": false,
      "note": "NO renal adjustment needed"
    }
  },

  "drugs_no_adjustment": [
    "ceftriaxone",
    "metronidazole",
    "azithromycin",
    "doxycycline",
    "linezolid"
  ],

  "nephrotoxic_antibiotics": {
    "high_risk": [
      "vancomycin",
      "aminoglycosides",
      "amphotericin_b"
    ],
    "moderate_risk": [
      "cefepime",
      "piperacillin_tazobactam"
    ],
    "monitoring": "Monitor SCr/BUN daily if on nephrotoxic agents",
    "avoid_combinations": "Avoid vancomycin + aminoglycoside if possible"
  },

  "calculation_methods": {
    "cockcroft_gault": {
      "formula": "((140-age) × IBW × (0.85 if female)) / (72 × SCr)",
      "units": "mL/min",
      "note": "Most commonly used for antibiotic dosing"
    },
    "mdrd": {
      "note": "Less commonly used for antibiotic dosing, reports as mL/min/1.73m2"
    }
  },

  "special_populations": {
    "obesity": {
      "note": "Use adjusted body weight for hydrophilic drugs (vancomycin, aminoglycosides)",
      "formula": "IBW + 0.4 × (TBW - IBW)"
    },
    "critical_illness": {
      "note": "Augmented renal clearance may occur. Higher doses may be needed.",
      "monitoring": "Consider therapeutic drug monitoring"
    },
    "elderly": {
      "note": "Age >65 → assume some renal impairment even if SCr normal",
      "recommendation": "Calculate CrCl using Cockcroft-Gault"
    },
    "dialysis": {
      "hemodialysis": {
        "note": "Dose after dialysis session. Check if drug is dialyzable.",
        "timing": "Give supplemental dose after HD"
      },
      "peritoneal_dialysis": {
        "note": "Different dosing than HD. Consult pharmacy."
      }
    }
  },

  "dose_adjustment_algorithm": {
    "step_1": "Calculate CrCl using Cockcroft-Gault",
    "step_2": "Determine CrCl category (normal, mild, moderate, severe, dialysis)",
    "step_3": "Look up drug in adjustment table",
    "step_4": "If adjustment required, apply appropriate dose/frequency change",
    "step_5": "If nephrotoxic drug, add monitoring recommendation",
    "step_6": "Return adjusted dose"
  },

  "consultation_triggers": {
    "pharmacist": [
      "Dialysis patients",
      "Multiple nephrotoxic agents",
      "Vancomycin dosing",
      "CrCl <15 mL/min"
    ],
    "nephrologist": [
      "Acute kidney injury on antibiotics",
      "Rapidly changing renal function"
    ]
  },

  "notes": [
    "Ceftriaxone and metronidazole do NOT require renal adjustment",
    "Vancomycin REQUIRES trough monitoring and dose adjustment",
    "Cefepime must be dose-adjusted to prevent neurotoxicity",
    "Dialysis patients need post-dialysis dosing",
    "Elderly patients should have CrCl calculated (may be impaired despite normal SCr)"
  ]
}
